Speaker Biographies :: HDMA 2011 Distribution Management Conference

Speaker Biographies


Anne-Marie Aldrich, PharmD District Pharmacy Supervisor, Palm Beach South #22 Walgreen Company
	Dr. Anne-Marie Aldrich, PharmD is District Pharmacy Supervisor, Palm Beach South #22 for Walgreen Company. She has been working in the pharmacy arena for 25 years and has been a licensed pharmacist since 1998 after graduating from Nova Southeastern University in Fort Lauderdale, Fla. During pharmacy school she joined Walgreen Company as an Intern, then Staff Pharmacist, Pharmacy Manager and now Pharmacy Supervisor for past 10 years. Currently she supervises 36 stores in Palm Beach County. Dr. Aldrich works with the local health department on various projects, most recently flu vaccination awareness and now emergency preparedness, connecting Retail Community Pharmacy with the Health Department.

Daniel G. Bellingham Director, State Government Affairs HDMA
	Daniel G. Bellingham is Director, State Government Affairs at HDMA. Bellingham is currently responsible for state advocacy efforts at both the legislative and regulatory levels and has been with HDMA since 2002. Prior to joining HDMA, he covered healthcare issues for corporate and association clients as a legislative analyst at Stateside Associates, a state legislative and regulatory monitoring company. He also has experience as a legislative associate in the Oregon legislature. Bellingham holds a BA in Political Science from the University of Oregon.

Joshua M. Bolin Government Affairs Director National Association of Boards of Pharmacy
	Josh Bolin is the Government Affairs Director for the National Association of Boards of Pharmacy (NABP), an international organization whose membership includes every state board of pharmacy in the United States and state or provincial pharmacy regulating agencies in Canada, Australia, New Zealand and South Africa. Bolin joined NABP in late 2005. He currently oversees the association’s Government Affairs Department, which provides support and assistance to the boards of pharmacy as they seek to develop rules and regulations that protect the public health.

Scott Bradford Vice President, Reverse Logistics McKesson Corporation
	Scott Bradford currently manages reverse distribution for McKesson and its healthcare provider customers, including the return of products to the manufacturer. Bradford’s 17-year career with McKesson has included positions focused on centralized transaction processing, field operations and financial planning and analysis. He has spent the last 11 years working in the area of reverse logistics. Prior to McKesson, Bradford worked for six years with Deloitte & Touche and the freight forwarding industry. Bradford earned his BS in Business Administration at the University of California, Berkeley.

John W. Brennan President and Managing Director Arthur D. Little, Inc.
	John Brennan is the President and Managing Director of Arthur D. Little, Inc. leading the firm's Pharmaceutical, Biotechnology and Health Care consulting businesses in the United States, Canada and Latin America. Mr. Brennan began his career locating venture-capital financing for early-stage technology firms and developing their growth strategies through to Initial Public Offerings. In 1989, Mr. Brennan joined Arthur D. Little and spent the next decade in a variety of management consulting positions leading major corporate- and technology-based strategic initiatives across North America, Europe and Asia. Mr. Brennan left the firm in 1998 to become Senior Vice President of Corporate Development at Protocare, Inc. as well as President and Head of R&D at ReasonEdge Technologies, Inc. In January 2004, Mr. Brennan returned to Arthur D. Little where he serves as an Officer of the Company and a Member of the Board of Directors. Mr. Brennan holds a BA from the College of the Holy Cross as well as master's degrees from Harvard University and Northeastern University.

Terry L. Carrico Vice President, Corporate Security McKesson Corporation
	Terry Carrico is Vice President of Corporate Security and Safety Operations for McKesson Corporation. In this role, he is responsible for leading all aspects of security and safety operations, including program development in the areas of security and safety standards, physical security, supply chain security, security awareness and workplace violence prevention. Prior to joining McKesson in 2007, Carrico was employed by Pfizer as the Director of Global Asset Protection. In 2003 he retired from the U.S. Army Military Police Corps as a Colonel after 24 years of service. Carrico holds a BS in Criminal Justice from Eastern Kentucky University and an MS in Forensic Science from The George Washington University.

Ed Crimmins Partner Kindler & Crimmins Associates
	Ed Crimmins is a Partner with Kindler & Crimmins Associates (KCA) and has more than 18 years of retail inventory management experience. KCA is an independent consulting company with broad-based expertise in the areas of inventory management and reverse logistics in the pharmaceutical industry and provides a unique, retailer-based perspective. Prior to joining KCA, Crimmins served as the Senior Director, Pharmacy Returns for Rite Aid Corporation. During his more than 12 years with Rite Aid, he was responsible for various aspects of reverse logistics and inventory management programs within the company, including oversight of the pharmaceutical reverse logistics physical and financial process flow. Crimmins holds a degree from the State University of New York at Albany.

Rolando DeCardenas Vice President and General Manager Oncology Rx US Oncology
	Rolando DeCardenas is Vice President and General Manager of US Oncology Specialty, LP; US Oncology Clinical & Research Pharmacy distribution center; OncologyRx Care Advantage; and esoteric oncology lab services for US Oncology, a division of McKesson Corporation and one of the nation's largest cancer treatment and research networks. DeCardenas led the development and construction of the company’s first distribution facility, which today supports the network’s distribution needs and of Care Advantage, a national oncology pharmacy developed by US Oncology to support the delivery and management of oral therapies. Prior to joining US Oncology, DeCardenas was a Regional Vice President for AmerisourceBergen Corporation and Vice President of Distribution for Bergen Brunswig (which was later acquired by AmerisourceBergen). He previously served as the Vice President of the Specialty & Biotech Distributors Association, is a member and past co-chair of HDMA’s Industry Relations Council and serves on the Center for Healthcare Supply Chain Research’s Board of Directors. DeCardenas holds a bachelor’s degree in Economics from Florida International University.

Patrick J. DeGrace Director, Customer Care Hospira Worldwide, Inc.
	Patrick DeGrace is Director, Customer Care for Hospira Worldwide, Inc. In this role he also acts as Hospira’s site director in Pleasant Prairie, Wis. and leads the company’s supply channel logistics group. DeGrace joined Abbott in 1980 and held various positions in sales, sales management and national account management, trade relation operations and customer care management. He was appointed to his current position in December 2004. DeGrace holds a bachelor's degree in Biology from St. Cloud State University in Saint Cloud, Minn.

Chris Doerr Associate Director, Client Financial Services Cephalon, Inc.
	Chris Doerr is Associate Director, Client Financial Services for Cephalon, Inc. Chris’s responsibilities include managing Cephalon’s Distribution Services Agreement compliance and scorecarding, Wholesaler Trade Relations and the U.S. Commercial Accounts Receivable portfolio. He currently co-chairs HDMA’s eCommerce Task Force. Prior to joining Cephalon, he held positions of increasing responsibility within Procurement, Supply Chain Management and Finance at AmerisourceBergen. Doerr holds a BS in Finance from Albright College and is pursuing an MBA – Pharmaceutical Marketing at St. Joseph’s University’s Erivan K. Haub School of Business.

David L. Durkin, Esq. Principal Olsson Frank Weeda Terman Bode Matz PC
	David Durkin is a Principal at Olsson Frank Weeda Terman Bode Matz P.C. He has been with the firm since 1988. Durkin's practice is concentrated in federal civil and criminal litigation and administrative proceedings, including court challenges to FDA, USDA, DEA regulatory and enforcement initiatives and ITC proceedings. Prior to joining the firm, Durkin served a two-year appointment as Law Clerk to the Honorable Jaime Pieras, Jr., United States District Judge for the District of Puerto Rico. He received his bachelor’s degree in Philosophy from John Carroll University, and holds a JD from the Catholic University of America.

Charles Forsaith Corporate Director, Supply Chain Security Purdue Pharma L.P.
	Charles Forsaith joined Purdue Pharma in 2001 and currently serves as its Corporate Director for Supply Chain Security. Forsaith served as a New Hampshire State Police Officer for more than 20 years and worked in supervisory capacities in the Major Crime, Narcotics and Intelligence Units. Forsaith has given lectures on Criminal Justice and Security at such organizations as Notre Dame College, the U.S. Merchant Marine Academy and the FBI. He is a member of the American Society of Industrial Security, the Transported Asset Protection Association, the National Association of Drug Diversion Investigators and the International Association of Chiefs of Police.

Perry L. Fri Senior Vice President, Industry Relations, Membership & Education Healthcare Distribution Management Association (HDMA)
	Perry L. Fri is HDMA’s Senior Vice President of Industry Relations, Membership and Education. In his current position, Fri is responsible for the direction, supervision and development of industry initiatives that facilitate improved business processes and operational efficiencies in the healthcare supply chain. Fri most recently served as Vice President of Industry Relations and Program Development for the Health Industry Distributors Association (HIDA). Prior to joining HIDA, Fri was a consultant for The Hale Group. He was also Vice President of Industry Alliances for Instill Corporation, and was the Director of Supply Chain Management for NWDA (now HDMA). Fri holds a BA in History from the University of Maryland.

Cathy A. Gallagher Associate Section Chief Liaison and Policy Section Office of Diversion Control Drug Enforcement Administration
	Cathy Gallagher currently serves as Associate Section Chief of the Liaison and Policy Section in the Office of Diversion Control, and is responsible for overseeing the Liaison, Policy and Regulatory Drafting Units. These three elements support DEA’s mission by drafting and disseminating regulations; designing and proposing national legislation; providing leadership and advice on state legislation and regulatory initiatives; and communicating with industry and their representative associations as well as the Drug Enforcement Administration’s regulatory and law enforcement counterparts at the federal, state and local levels. Gallagher began her work with the DEA while in college and was hired as a full-time Diversion Investigator in 1985. In this role, she routinely conducted inspections of DEA Registrants, such as manufacturers and distributors of controlled substances, as well as criminal, civil and administrative investigations of pharmacists, physicians and well-organized prescription rings. Gallagher received a BS in Economics and Political Science from Regis University in Denver in 1984 and interned with the United Nations in Vienna, Austria in 1982.

John M. Gray President and CEO HDMA
	John M. Gray is President and CEO of the Healthcare Distribution Management Association (HDMA), the national association representing primary healthcare distributors. He reports directly to the HDMA Board of Directors and is responsible for overseeing all HDMA operations and activities. Gray also serves as President and CEO of the Center for Healthcare Supply Chain Research, formerly the HDMA Foundation. Prior to joining HDMA, he served as Food Distributor International’s (FDI’s) Executive Vice President and General Counsel. When FDI merged with the Food Marketing Institute, Gray became the President and CEO of the International Food Distributors Association (IFDA). Gray holds an AB from the College of William and Mary; an MBA from the Wharton School, University of Pennsylvania; and a JD from the University of Virginia School of Law.

Mark Halperin Senior Political Analyst, MSNBC and TIME Magazine and Co-author, Game Change
	Mark Halperin, Editor-at-Large and Senior Political Analyst for TIME, covers politics, elections and government for the magazine and TIME.com. Halperin also is the creator and author of TIME.com’s “The Page,” a news and analysis tip sheet that gathers and edits the latest political stories, campaign ads, TV clips, videos and campaign reactions from every news source, along with Halperin’s own analysis. In addition, Halperin is Senior Political Analyst for MSNBC, where he appears regularly on Morning Joe and other programs on the cable channel. Prior to joining TIME in April 2007, Halperin worked at ABC News for nearly 20 years, where he covered five presidential elections and served as Political Director from November 1997 to April 2007. In that role, he was responsible for political reporting and planning for the network's television, radio and Internet political coverage. He also appeared regularly on ABC News TV and radio as a Correspondent and Analyst, contributing commentary and reporting during election night coverage, presidential inaugurations and State of the Union speeches. At ABC, Halperin reported on every major American political story, including working as a full-time reporter covering the Clinton presidential campaign in 1992 and the Clinton White House. He also covered major non-political stories, such as the O.J. Simpson criminal trial and the Oklahoma City bombing. Additionally, Halperin founded and edited the online publication The Note on abcnews.com, which was characterized as the most influential daily tipsheet in American politics by publications including The New Yorker, The New York Times, The Wall Street Journal and Vanity Fair. He is the co-author of the New York Times number one bestseller Game Change: Obama and the Clintons, Palin and McCain, and the Race of a Lifetime (Harper, 2010); author of The Undecided Voter’s Guide to the Next President (Harper Perennial, 2007); and co-author of The Way to Win: Taking the White House in 2008 (Random House, 2006). Halperin received his BA from Harvard University and resides in New York City with Karen Avrich.

Jeff Heath Director, Distribution Operations Obagi Medical Products, Inc.
	Jeff Heath is the Director, Distribution Operations, at Obagi Medical Products, Inc. In this role, Heath manages distribution strategies to support Obagi’s internal distribution center and 3PL partner. Prior to his current position, Heath served as a Senior Manager Vendor Managed Inventories for Leiner Health Products, where he managed inventory supplies for Costco, CVS, Kroger, Safeway and other major retailers. He also served in multiple supply chain positions for Allergan Pharmaceuticals. Heath received a BS in Management and an MBA from the University of Redlands.

Peyton Howell, MHA President, Consulting Services AmerisourceBergen Corporation
	Peyton Howell has more than 20 years of healthcare policy and reimbursement experience focused on commercialization services for new pharmaceutical and biotech products. Today that includes products that may have a variety of REMS requirements, reimbursement challenges and other requirements. As President of Consulting Services she leads Lash Group and Xcenda business units that provide pharmacoeconomic consulting; managed markets strategy; health outcomes; and the design and management of product support programs, including reimbursement support, adherence, REMS and patient access hubs. Ms. Howell was a Founder and President of the Lash Group, which became part of AmerisourceBergen in 1998. Under her leadership the group has grown from a boutique consulting firm to more than 1,200 associates and consultants nationwide, with a client base that includes the country’s most innovative and respected pharmaceutical companies. Howell also supports health policy issues as an author and national speaker for AmerisourceBergen Corporation. She received an MHA from The Ohio State University and a BA from the University of Illinois. She resides in Charlotte, N.C. and was recognized as the 2004 Charlotte Businesswoman of the Year.

Giovanni Iachello Expert, Strategy Practice McKinsey & Company
	Giovanni Iachello is an Expert in McKinsey & Company’s Strategy Practice. Iachello manages McKinsey’s Global Forces Service Line, where he assists clients in understanding the impact of long-term global trends and leads McKinsey research on this topic. He has served a variety of clients across industries on topics ranging from long-term strategy, to market entry, product development and M-and-A strategy. Prior to joining McKinsey, Iachello worked at Intel Research and Altoprofilo SPA (a consulting firm in Milan, Italy). He holds a Laurea Degree cum laude in Informatics Engineering from the University of Padua, Italy and a PhD in Computer Science from the Georgia Institute of Technology.

Doug Long Vice President Industry Relations IMS Health, Inc.
	Doug Long is Vice President of Industry Relations at IMS Health, the world’s largest pharmaceutical information company. IMS Health provides consulting services and an extensive product portfolio to the pharmaceutical industry in more than 101 countries worldwide. Since joining IMS in 1989, Doug has been active in the successful implementation of data health databases and has a unique perspective on the changing U.S. and global healthcare marketplace and pharmaceutical distribution. Doug Long’s Industry Year in Review features trends and forecasts of the U.S. market. Wholesalers, retailers, manufacturers and multiple trade associations rely on Doug for guidance, direction and industry expertise. Doug is a frequent industry speaker and permanent member of the Editorial Advisory Board of HealthCare Distributor magazine. He was a recipient of the 2004 Nexus Award for Lifetime Achievement and IMS’ prestigious Summit Award in 2003. Prior to IMS Health, Doug was at Nielsen Market Research for 16 years in sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and an MBA from Fairleigh Dickinson University.

Terri Madison, PhD, MPH Vice President, Epidemiology & Risk Management Xcenda, part of AmerisourceBergen Consulting Services
	Terri Madison, PhD, MPH, is Vice President at Xcenda, where she leads the Epidemiology and Risk Management consulting practice. Dr. Madison and her team work collaboratively with colleagues across AmerisourceBergen to deliver services that help clients use evidence-based science and risk management methods to reinforce the safe and appropriate use of their products. Prior to joining Xcenda, Dr. Madison was President of i3 Drug Safety and Chief Operating Officer of STATPROBE, Inc. With 25 years’ experience, she is an industry expert in drug safety and has been an invited speaker and panelist on topics regarding risk minimization, data privacy and issues surrounding the reporting of adverse events from administrative databases. Dr. Madison received her PhD and MPH in Epidemiology from the University of Michigan.

Dr. Ian Morrison Author, Consultant and Futurist
	Dr. Ian Morrison is an internationally-known author, consultant and futurist specializing in long-term forecasting and planning, with particular emphasis on healthcare and the changing business environment. Morrison is the author of Healthcare in the New Millennium: Vision, Values and Leadership. His previous book, The Second Curve — Managing The Velocity of Change, was a New York Times Business Bestseller and Businessweek Bestseller. Morrison is a founding partner in Strategic Health Perspectives (SHP), a forecasting service for clients in the healthcare industry; President Emeritus of the Institute for the Future (IFTF); and Chair of IFTF’s Health Advisory Panel. Morrison holds an interdisciplinary PhD in urban studies from the University of British Columbia; an MA in geography from the University of Edinburgh, Scotland; and a graduate degree in urban planning from the University of Newcastle-upon-Tyne, England.

Erin Mullen, RPh, PhD Assistant Vice President Rx Response
	Dr. Erin Mullen is the Assistant Vice President of Rx Response for the Pharmaceutical Research and Manufacturers of America (PhRMA). In this role, Dr. Mullen serves as co-chair of the Healthcare Sector Coordinating Council, an advisory council to DHS and HHS on such healthcare matters as Critical Infrastructure. She also is a member of the National Disaster Medical System as a Clinical Pharmacy Unit Leader. Her disaster deployments have included multiple hurricane responses, an extended deployment for Hurricanes Katrina and Rita and the Haiti Earthquake. Before joining PhRMA, Dr. Mullen practiced community pharmacy and then became the first Public Health Preparedness Pharmacist for the Florida Department of Health, bringing her experience as a field responder and clinical care provider to address public health preparedness issues requiring pharmaceuticals and pharmaceutical care. Dr. Mullen graduated from the Massachusetts College of Pharmacy with a BS in Pharmacy in 1992. She earned her PhD in Microbiology and Immunology from the University of Miami in 2000.

Jim Palmer Hall of Fame Pitcher for the Baltimore Orioles
	Jim Palmer, elected to the Hall of Fame in 1990, spent his entire 20-year pitching career with the Baltimore Orioles (1966-85). He is the Orioles' all-time leader in virtually every pitching category including wins, strikeouts, shutouts, complete games and innings pitched. He is the only American League Hall of Fame pitcher to win the Cy Young Award three times, and also earned four Gold Glove Awards. Palmer is one of only three pitchers in American League history to have won 20 or more games in eight seasons and one of only five pitchers in Orioles history to have his uniform number retired. Palmer had an 8-3 record with a 2.61 ERA in post-season play, and in 1983 became the only pitcher in baseball history to win a World Series game in three different decades. Palmer's broadcasting career has included work for ABC TV, Home Team Sports and ESPN, for which he earned an ACE cable award nomination. He has been the spokesperson for Jockey International and The Money Store, and has served as the national sports chairman for the Cystic Fibrosis Foundation for more than two decades. Palmer’s charitable and community causes also include D.A.R.E., Arthritis, Alzheimer’s, Autism, Grant a Wish, Special Olympics and local recycling programs.

Cynthia Reilly, BS Pharm Director, Practice Development Division American Society of Health-System Pharmacists
	Cynthia Reilly serves as Director, Practice Development Division for the American Society of Health-System Pharmacists (ASHP). In this role, she oversees the Society’s work related to the quality and safety of medication use by serving as a frontline advocate for ASHP members to national health care professional organizations, government and other entities that influence patient care. She also serves as Secretary of ASHP’s Council on Therapeutics. Reilly began her career at ASHP in 1997 after graduating from Temple University School of Pharmacy. Since that time, she has served in a variety of capacities, including work in the publishing and continuing education groups. In 2006, she departed ASHP to serve as Senior Marketing Manager on the communications contract for the Agency for the Healthcare Research and Quality. In 2007, she returned to ASHP to coordinate the Society’s efforts related to therapeutic policy and the clinical role of the pharmacist. Most recently, she led ASHP’s efforts to co-convene the Drug Shortages Summit. Reilly’s professional interests include clinical policy, quality measure development and implementation and the use of social marketing to improve the translation of evidence to practice.

Susan Rider President Rider & Associates
	Susan Rider is President of Rider & Associates, a consulting firm specializing in supply chain, operations and marketing consulting. Rider has been in the logistics industry for more than 15 years. Previously, she was Senior Vice President at Intelligrated, a material handling systems company specializing in conveyor systems. Prior to Intelligrated, Rider has held the positions of Vice President at RedPrairie and Vice President at Manhattan Associates. She also served on the design team for Amazon.com during the initial design of its distribution network. Rider serves on the Editorial Advisory Board for Modern Material Handling and Distribution Center Management.

TJ Rizzo Director of Sales Cold Chain Technologies
	TJ Rizzo is responsible for Cold Chain Technologies’ sales and customer service departments and continued growth initiatives. He previously managed key accounts as a Strategic Account Engineer for Cold Chain. Rizzo has direct contact with clients, as well as corporate responsibilities. He also is extensively involved in industry groups including the PCCIG “Last Mile” task force and “Risk Management for Temperature Controlled Distribution” task forces. Rizzo has a strong understanding of industry requirements including USP 1079, PDA Technical Report 39 and FDA regulations, as well as logistics as they pertain to the pharmaceutical and biotech sectors. Rizzo graduated from Pennsylvania State University with a bachelor’s degree in Mechanical Engineering and is pursuing his MBA from the University of Massachusetts.

Mary Kay Rust Director of US Distribution Operations Lilly USA, LLC
	Mary Kay Rust has been in a leadership position with Lilly for 13 years. In her current role as Director of US Distribution Operations, she has responsibility for the distribution of Lilly products throughout the United States. Her current role also oversees import and export processes and product returns. Prior to joining Lilly, Mary Kay spent 15 years in the avionics and medical device manufacturing industries. Rust received a BS in Industrial Engineering from Purdue University and an MBA from Indiana University. She is certified as a Professional Project Manager (PMP) and Six Sigma Green Belt.

Larri Short Partner, Health Law Group Arent Fox, PLLC
	Larri Short, Esq. is a Partner in the Health Law Group at Arent Fox, PLLC. Short focuses on healthcare regulatory matters, including Medicare and Medicaid reimbursement; Medicaid and state supplemental drug rebate programs; PHS and VA pricing; fraud and abuse; and sales, marketing and clinical trial compliance issues. Short has represented healthcare provider and pharmaceutical clients in qui tam actions filed under federal and state False Claims Acts and is involved in the defense of pharmaceutical clients. Short holds a BS from the University of Michigan, an MA from Duke University and a JD from the University of North Carolina School of Law.

Jeffery D. Stirling Manager of Distribution Operations Lilly USA, LLC
	Jeff Stirling is Distribution Operations Manager with Eli Lilly and Company, with responsibility for all aspects of East and West Coast distribution operations. Stirling has worked in Distribution for 10 of his 13 years at Lilly. Prior to Eli Lilly, he worked for Ford Motor Company in various operations and engineering roles. He holds a BS and an MS in Industrial Engineering from Purdue University.

Steve Tadevich Director, Product Serialization Technologies McKesson Corporation
	Steve Tadevich is Director, Product Serialization Technologies and a Six Sigma Black Belt in the Business Technology Solutions group for McKesson Pharmaceutical. His responsibilities include McKesson's initiatives in serialization, track and trace, e-Pedigree, RFID and supply chain security. He also works as a business technology liaison with Corporate Government Affairs. Tadevich has been at McKesson for 25 years in various operations and information technology positions. He is a member of several GS1 groups and represents McKesson on HDMA’s Business Technology Committee.

Laurel Todd Managing Director, Reimbursement & Health Policy Biotechnology Industry Organization
	Laurel Todd is Managing Director, Reimbursement and Health Policy at the Biotechnology Industry Organization (BIO). Todd directs the Association’s policy efforts related to Medicare, Medicaid and health reform. Prior to joining BIO, Laurel advised pharmaceutical, biotechnology, medical device and other medical technology and physician groups on Medicare coding, coverage and reimbursement issues at HillCo Partners, LLC (a public policy consulting firm). Laurel also previously served as Special Assistant to the Deputy Administrator and Deputy Capital Markets Advisor for the Centers for Medicare & Medicaid Services in Washington, D.C. Laurel holds undergraduate degrees from the University of Pennsylvania and an MBA from Georgetown University.

Ed Vianco, CPA Vice President and Controller McKesson Pharmaceutical Supply Solutions
	Ed Vianco is a CPA and Vice President and Controller for McKesson Pharmaceutical Supply Solutions. He has more than 25 years of experience in various accounting and finance roles. Vianco is a current member and past chairman of the Center for Healthcare Supply Chain Research’s Industry Benchmarking Committee. Prior to his 13 years at McKesson, he served as an Audit Manager at KPMG, a Big Four national accounting firm; Vice President of Finance for a regional home healthcare company; and as a Controller for a national real estate and hotel management company. Vianco holds a BA and an MBA from Baylor University.

Celia Weber Director, Branded Rx AmerisourceBergen Corporation
	Celia Weber is Director, Branded Rx at AmerisourceBergen Drug Corporation. Her current responsibilities include fee-for-service, new product launches, new supplier set up and branded Rx marketing. Prior to joining ABC in 2008, Weber worked for a variety of wholesalers with roles in supplier relations, operations and national account management. She also has generic trade and sales force management experience. A native of Wisconsin, Weber completed her undergraduate work in Human Resources at North Texas State University.

Geoff Werth Director, Federal Government Relations US Oncology
	Geoff Werth is Director,Federal Government Relations in US Oncology's Washington, D.C. office. In this role, Geoff directs the network’s federal legislative and regulatory initiatives; related public policy research and analysis projects; and public outreach and grassroots advocacy efforts in support of the network’s federal public policy goals. Werth has been with US Oncology for more than two years and has been working in the legislative and political arena since 1997. Prior to joining the company, Werth worked for nearly four years in federal government relations for the American College of Surgeons. This followed seven years of federal legislative experience working as a Policy Advisor to Minority Leader Dick Gephardt (D-Mo.) and Congressman Bart Stupak (D-Mich.) Geoff received his MA in Public Policy from the University of Maryland and his BA in Biology from the University of Kansas.

Amy A. Winnen Director, Trade and Distribution Vertex Pharmaceuticals
	Amy A. Winnen is the Director, Trade and Distribution, at Vertex Pharmaceuticals, Inc. In this role, Winnen designs and implements the global commercial distribution strategies to ensure Vertex is well prepared to successfully and independently commercialize products. Prior to joining Vertex, she managed distribution and related commercial operations functions for Millennium Pharmaceuticals. Additionally, Winnen has several years of experience in pharmaceutical business consulting. She holds an MBA from the Simmons School of Management and a BA in Economics and Sociology from St. Lawrence University.

Robert Young Associate Director Delivery Management TEVA Pharmaceuticals USA
	Robert Young works for TEVA Pharmaceuticals USA in the Delivery Management/Business Analyst organization of Information Technology. He is the global IT lead for TEVA Pharmaceuticals for their serialization initiative. With experience in consulting, retail distribution and pharmaceutical industries, Young has a background with WMS implementations, ERP integrations and EDI processes. Young has been working with the pedigree process since the initial requirement in Florida. Most recently, he has been responsible for designing and implementing the IT systems and integrations for the serialization process to meet the California and global requirements. Robert has an Engineering degree from Clarkson University and an MBA from the University of Miami.

Chris Zimmerman Vice President, Corporate Security and Regulatory Affairs AmerisourceBergen Corporation
	Chris Zimmerman is Vice President, Corporate Security and Regulatory Affairs, for AmerisourceBergen Corporation. He has been in the healthcare industry for 25 years, the last 22 years with AmerisourceBergen, specializing in security and regulatory issues that impact pharmaceutical distribution. He is an active member of HDMA’s Government and Public Policy Council and its Regulatory Affairs Committee. He also is Ch air of the ASIS Pharmaceutical Security Council's Membership Committee and has the credentials of Certified Protection Professional and Certified Fraud Examiner. Zimmerman holds a Degree in Criminal Justice from California State University, Fullerton.